GE HealthCare Receives FDA Clearance of Allia IGS Pulse for Cardiac Imaging

November 2, 2023

The FDA has given GE HealthCare’s Allia IGS Pulse 510(k) clearance for cardiac imaging regardless of patient size.

With Allia IGS Pulse, clinicians are able to get exceptional image quality for large and bariatric patients with a BMI of greater than 30. As part of its new image chain, the system features a monopolar x-ray tube used to capture images for interventional procedures, the company said.

The small footprint of the tube also helps clinicians reach steep angulation for better understanding of coronary artery anatomy, even with the 30cm detector configurations.

The Allia IGS Pulse was introduced at the Transcatheter Cardiovascular Therapeutics 2023 conference last week.

To read the whole story, click here to subscribe.

FDA Requirements for Rare Oncology Drugs Often Drug-Drug Interactions Say Scholars

GE HealthCare Receives FDA Clearance of Allia IGS Pulse for Cardiac Imaging

Upcoming Events

Medical Device Cybersecurity: Latest Regulatory Developments

Thriving in Clinical Research – Overcoming Common Challenges as a Site: Part 3 – Site Resourcing

Proactive Supplier Management Using Quality Agreements

FDA Inspection Overhaul: How Things Have Changed in 2023

MAGI 2024: The Clinical Research Conference

Featured Products

FDA, FTC and DOJ Enforcement of Medical Device Regulations

Using Real-World Evidence in Drug and Device Submissions

Featured Stories

FDA Requirements for Rare Oncology Drugs Often Drug-Drug Interactions Say Scholars

Data ‘Incident’ Is Now a Breach, Henry Schein Told Customers

Lilly’s Claims of Mounjaro Trademark Infringement Get ITC Investigation

Positive Findings Generated by Element Science’s Jewel Wearable Cardiac Defibrillator

The Revised ICH E8: A Guide to New Clinical Trial Requirements